RT Journal Article
SR Electronic
T1 Coronavirus GenBrowser for monitoring the transmission and evolution of SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.23.20248612
DO 10.1101/2020.12.23.20248612
A1 Yu, Dalang
A1 Yang, Xiao
A1 Tang, Bixia
A1 Pan, Yi-Hsuan
A1 Yang, Jianing
A1 Duan, Guangya
A1 Zhu, Junwei
A1 Hao, Zi-Qian
A1 Mu, Hailong
A1 Dai, Long
A1 Hu, Wangjie
A1 Zhang, Mochen
A1 Cui, Ying
A1 Jin, Tong
A1 Li, Cui-Ping
A1 Ma, Lina
A1 ,
A1 Su, Xiao
A1 Zhang, Guoqing
A1 Zhao, Wenming
A1 Li, Haipeng
YR 2021
UL http://medrxiv.org/content/early/2021/10/19/2020.12.23.20248612.abstract
AB Genomic epidemiology is important to study the COVID-19 pandemic and more than two million SARS-CoV-2 genomic sequences were deposited into public databases. However, the exponential increase of sequences invokes unprecedented bioinformatic challenges. Here, we present the Coronavirus GenBrowser (CGB) based on a highly efficient analysis framework and a movie maker strategy. In total, 1,002,739 high quality genomic sequences with the transmission-related metadata were analyzed and visualized. The size of the core data file is only 12.20 MB, efficient for clean data sharing. Quick visualization modules and rich interactive operations are provided to explore the annotated SARS-CoV-2 evolutionary tree. CGB binary nomenclature is proposed to name each internal lineage. The pre-analyzed data can be filtered out according to the user-defined criteria to explore the transmission of SARS-CoV-2. Different evolutionary analyses can also be easily performed, such as the detection of accelerated evolution and on-going positive selection. Moreover, the 75 genomic spots conserved in SARS-CoV-2 but non-conserved in other coronaviruses were identified, which may indicate the functional elements specifically important for SARS-CoV-2. The CGB not only enables users who have no programming skills to analyze millions of genomic sequences, but also offers a panoramic vision of the transmission and evolution of SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a grant from the National Key Research and Development Project (No. 2020YFC0847000).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll timely-updated data are freely available at https://bigd.big.ac.cn/ncov/apis/. The desktop standalone version provides the full function of CGB and has a plug-in module for the eGPS software (http://www.egps-software.net/egpscloud/eGPS_Desktop.html).